Knappskog, S., Berge, E. O., Chrisanthar, R., Geisler, S., Staalesen, V., Leirvaag, B., . . . Lønning, P. E. (2015). Concomitant inactivation of the p53‐ and pRB‐ functional pathways predicts resistance to DNA damaging drugs in breast cancer in vivo. Mol Oncol.
استشهاد بنمط شيكاغوKnappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.
MLA استشهادKnappskog, Stian, et al. "Concomitant Inactivation of the P53‐ and PRB‐ Functional Pathways Predicts Resistance to DNA Damaging Drugs in Breast Cancer In vivo." Mol Oncol 2015.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.